Health rising blog post, by Cort Johnson, 5 September 2016: Hanson’s Metabolomics ME/CFS Study Validates Naviaux’s Core Finding
Within days of Naviaux’s possibly groundbreaking metabolomics paper, Maureen Hanson told a SolveME/CFS Initiative webinar audience that her metabolomics study indicated ME/CFS was a hypometabolic disorder as well. Check out what she found plus learn about her exciting new mitochondrial/immune work, and about the creation of a new ME/CFS center in one of the top universities in the country.
Also check out a surprisingly long list of ongong metabolomics and read how a surprising metabolomics study could change the medical profession’s conception of depression.
the way Hanson was talking, it sounded like everything was done differently in the Hanson study. Nevertheless, Hanson’s core findings were strikingly similar to Naviaux’s. She found an almost across the board reduction in metabolite levels; fully eighty-eight percent of the metabolites in the ME/CFS patients were reduced (compared to 84% in Naviaux’s study.)